Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.
about
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patientsCirculating tumor cells in breast cancerEffectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysisClinical application of circulating tumor cells in breast cancer: overview of the current interventional trialsMinimal residual disease and circulating tumor cells in breast cancerPotential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current EvidenceCirculating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical studyTowards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.Circulating Tumor Cells in Early-Stage Breast Cancer.International study on inter-reader variability for circulating tumor cells in breast cancerHER2-positive circulating tumor cells in breast cancerCirculating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.Role of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China.Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.Circulating tumor cells in non-metastatic triple-negative breast cancer.A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapyCirculating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionAssessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy.May CTC technologies promote better cancer management?Markers for the identification of late breast cancer recurrence.Circulating tumor cells in newly diagnosed inflammatory breast cancer.Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticityThe HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response.Circulating tumor cells (CTCs) detected by RT-PCR and its prognostic role in gastric cancer: a meta-analysis of published literature.Future medical applications of single-cell sequencing in cancer.Clinical relevance and biology of circulating tumor cells.Invasive lobular carcinoma predicts micrometastasis in breast cancer.A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolationBiomarkers characterization of circulating tumour cells in breast cancer patientsDynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy.Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methodsExpression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsSimultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer PatientsDoes primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapyDifferential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancerClinical challenges in the molecular characterization of circulating tumour cells in breast cancer.Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer.
P2860
Q21284707-71BC8B1D-5B5F-4FFE-9AEB-6BA45A757852Q26774808-2F3CC73B-D11C-4BC7-BD15-524219B63972Q26777704-ED4FF93A-82DD-46FA-A8A4-A4A57004DCF6Q26827936-F734F12A-96D3-45E4-A0A5-4A6D46F2DF77Q27010152-83252917-5F81-42C8-A6E2-D1D79E9102E5Q28075850-70D51959-9721-4F82-9147-4187C8BF2AC4Q28535476-BF81C4DF-CF4F-4305-9EF1-A3522993D25AQ30445250-DAFA7DAC-461B-4626-B98E-2453D2F0669EQ31158116-08C3DAFD-B14A-4B86-AD9B-C2D828B1751AQ33579111-12A8E327-4674-4626-9DA0-E3CF0376FD02Q33738688-C22B700F-0486-4689-A4F4-D9F5705D08D2Q33802925-BBB33CEA-120A-43A5-9C60-5C5C7E96E2C1Q33829270-13DF7F69-E467-4AFA-B72A-F22AECEDE514Q33858981-B892641A-D355-4F22-AE92-C7939272AAFBQ33958981-DC25E64A-75C6-4E9B-9234-B6C36C3B18D6Q34111867-1224166E-CC37-4437-8997-5C8D0F2397C3Q34289862-D88607AF-A5C6-44EB-A003-A312C27D231DQ34316618-40B5D97E-2052-44D6-8E22-95CF958C4D25Q34496964-F14C37A8-2A50-4E5B-9CEB-DD4D062CCFA3Q34779138-47D51442-150B-49ED-937B-646FFA2100E1Q35016353-E16F9C3E-715F-4132-B685-E85F8A9CEE45Q35018949-A80DD89D-C9BF-4628-ADF9-54BB2125092FQ35052773-5279B816-860D-40A0-BB43-E6296FC15889Q35053624-7D6BF72D-394B-4262-90A6-490F1B9EAAADQ35124176-A77CE078-2740-482B-B9A5-37DC66A40C38Q35181440-12D7E524-E9F0-4713-9A59-13BEE71A56FAQ35182266-FAE81F7A-C00E-4567-B180-D98AF6C6CB82Q35558519-89E47E2A-4F51-4BD1-8E83-1BF5A3A822D1Q35889548-85E4CC89-42C9-47FA-BB41-5225A3978CA3Q36166242-58B965F3-CD5D-4F6D-95FC-515CB4ABDC5EQ36206190-A0BA8345-0A7D-49D2-A799-B34A225E576CQ36245346-385695BE-FD0B-4B49-B394-786770DC3E3AQ36285641-8B0111F7-5108-4639-B725-246C6FB5CA6FQ36369268-97BF5D3C-F1B3-4EA0-880B-756557A328B1Q36393149-5AFD256D-8678-47FF-9F1F-BC9C48526F5BQ36482582-D3DBC2EE-79E5-4AEB-BBE5-BC9600A4D465Q36574920-657E8544-BD4A-41AF-97D3-A2DDA53AE6AAQ36671882-D6355E21-9F58-401B-9F3F-18597828B01AQ36959162-F33019DA-D282-4524-99F2-BFA03B9000FEQ37015722-32D93E69-99FB-4AE0-9E9E-019D3BF19B58
P2860
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Single circulating tumor cell ...... n nonmetastatic breast cancer.
@en
Single circulating tumor cell ...... n nonmetastatic breast cancer.
@nl
type
label
Single circulating tumor cell ...... n nonmetastatic breast cancer.
@en
Single circulating tumor cell ...... n nonmetastatic breast cancer.
@nl
prefLabel
Single circulating tumor cell ...... n nonmetastatic breast cancer.
@en
Single circulating tumor cell ...... n nonmetastatic breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Single circulating tumor cell ...... n nonmetastatic breast cancer.
@en
P2093
F-C Bidard
J-Y Pierga
P de Cremoux
S Delaloge
S Giachetti
P2860
P304
P356
10.1093/ANNONC/MDP391
P577
2009-10-22T00:00:00Z